SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3QZ'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HXB_A_ROCA100_2 (HIV-1 PROTEASE) |
5vbu | CYTOCHROME P45021-HYDROXYLASE (Homosapiens) | 3 / 3 | ARG A 234THR A 201VAL A 198 | 3QZ A 502 (-3.8A)None3QZ A 502 (-4.6A) | 1.01A | 1hxbA-5vbuA:undetectable | 1hxbA-5vbuA:12.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NR6_A_DIFA501_1 (CYTOCHROME P450 2C5) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 9 | LEU A 105ALA A 113PHE A 114GLY A 301ALA A 302THR A 306 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A) | 1.07A | 1nr6A-4nkyA:44.8 | 1nr6A-4nkyA:32.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1R9O_A_FLPA501_1 (CYTOCHROME P450 2C9) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | LEU A 209ASP A 298GLY A 301ALA A 302THR A 306 | 3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A) | 0.93A | 1r9oA-4nkyA:43.3 | 1r9oA-4nkyA:32.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YAJ_K_BEZK4387_0 (CES1 PROTEIN) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 3 / 3 | TRP A 117LEU A 110LYS A 99 | HEM A 500 (-4.4A)3QZ A 501 (-4.3A)None | 1.39A | 1yajK-3qz1A:undetectable | 1yajK-3qz1A:23.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2A15_A_NCAA1001_0 (HYPOTHETICAL PROTEINRV0760C) |
5ier | OHP9 (syntheticconstruct) | 5 / 11 | TRP A 24ILE A 64LEU A 69LEU A 89TYR A 109 | 3QZ A 201 ( 4.5A)3QZ A 201 ( 4.4A)3QZ A 201 (-4.0A)3QZ A 201 ( 4.5A)None | 0.91A | 2a15A-5ierA:25.3 | 2a15A-5ierA:95.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q64_B_1UNB1001_2 (PROTEASE RETROPEPSIN) |
5vbu | CYTOCHROME P45021-HYDROXYLASE (Homosapiens) | 3 / 3 | ARG A 234THR A 201VAL A 198 | 3QZ A 502 (-3.8A)None3QZ A 502 (-4.6A) | 0.94A | 2q64A-5vbuA:undetectable | 2q64A-5vbuA:12.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Z77_D_NCAD200_0 (PUTATIVE STEROIDISOMERASE) |
5ier | OHP9 (syntheticconstruct) | 5 / 9 | TRP A 13TRP A 24LEU A 69LEU A 89TYR A 109 | None3QZ A 201 ( 4.5A)3QZ A 201 (-4.0A)3QZ A 201 ( 4.5A)None | 0.85A | 2z77D-5ierA:26.0 | 2z77D-5ierA:95.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_A_4PZA501_1 (CYTOCHROME P450 2E1) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 3 / 3 | ALA A 302THR A 306CYH A 442 | 3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 (-2.6A) | 0.69A | 3e4eA-4nkyA:43.8 | 3e4eA-4nkyA:31.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_B_4PZB501_1 (CYTOCHROME P450 2E1) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 3 / 3 | ALA A 302THR A 306CYH A 442 | 3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 (-2.6A) | 0.60A | 3e4eB-4nkyA:41.0 | 3e4eB-4nkyA:31.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HRD_B_NIOB5661_1 (NICOTINATEDEHYDROGENASE LARGEMOLYBDOPTERINSUBUNITNICOTINATEDEHYDROGENASE MEDIUMMOLYBDOPTERINSUBUNIT) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 4 / 8 | ILE A 205PHE A 114THR A 294ALA A 113 | 3QZ A 601 ( 3.4A)3QZ A 601 ( 4.1A)NoneHEM A 600 ( 2.9A) | 0.84A | 3hrdA-4nkyA:undetectable3hrdB-4nkyA:0.4 | 3hrdA-4nkyA:21.413hrdB-4nkyA:22.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RUK_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | ALA A 113PHE A 114TYR A 201ASN A 202ILE A 205LEU A 209ASP A 298ALA A 302THR A 306VAL A 366CYH A 442VAL A 482 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)None3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 ( 3.4A)HEM A 600 (-2.6A)3QZ A 601 (-4.1A) | 0.41A | 3rukA-4nkyA:63.0 | 3rukA-4nkyA:99.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RUK_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 12 | ASN A 202ILE A 205LEU A 105ALA A 302THR A 306CYH A 442 | 3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.2A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 (-2.6A) | 1.45A | 3rukA-4nkyA:63.0 | 3rukA-4nkyA:99.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RUK_B_AERB601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206LEU A 209ASP A 298GLY A 301ALA A 302THR A 306VAL A 482VAL A 483 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.38A | 3rukB-4nkyA:62.9 | 3rukB-4nkyA:99.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RUK_C_AERC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 9 / 9 | ALA A 113PHE A 114TYR A 201ASN A 202ILE A 205ARG A 239ASP A 298GLU A 305THR A 306 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)None3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.2A) | 0.43A | 3rukC-4nkyA:59.1 | 3rukC-4nkyA:99.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RUK_D_AERD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 11 / 11 | ALA A 113PHE A 114TYR A 201ASN A 202ILE A 205ARG A 239ASP A 298GLY A 301ALA A 302THR A 306VAL A 366 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)None3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 ( 3.4A) | 0.37A | 3rukD-4nkyA:59.3 | 3rukD-4nkyA:99.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_D_9PLD1_1 (CYTOCHROME P450 2A13) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 4 / 8 | ALA A 113PHE A 114ALA A 302THR A 306 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A) | 0.51A | 3t3sD-4nkyA:43.6 | 3t3sD-4nkyA:31.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IB4_A_ERMA2001_2 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 4 / 7 | ASP A 286LEU A 176GLN A 239LEU A 240 | 3QZ A 501 ( 4.7A)NoneNoneNone | 1.12A | 4ib4A-3qz1A:undetectable | 4ib4A-3qz1A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JEC_B_478B401_2 (HIV-1 PROTEASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | GLY A 301VAL A 178GLY A 444ILE A 443ILE A 179 | 3QZ A 601 ( 3.0A)NoneHEM A 600 ( 3.7A)HEM A 600 ( 4.1A)None | 0.94A | 4jecB-4nkyA:undetectable | 4jecB-4nkyA:13.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L4A_A_CAMA502_0 (CAMPHOR5-MONOOXYGENASE) |
5ier | OHP9 (syntheticconstruct) | 4 / 8 | PHE A 59THR A 16THR A 43LEU A 69 | 3QZ A 201 ( 4.5A)3QZ A 201 (-2.9A)3QZ A 201 (-3.2A)3QZ A 201 (-4.0A) | 0.98A | 4l4aA-5ierA:undetectable | 4l4aA-5ierA:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L4E_A_CAMA503_0 (CAMPHOR5-MONOOXYGENASE) |
5ier | OHP9 (syntheticconstruct) | 4 / 8 | PHE A 59THR A 16THR A 43LEU A 69 | 3QZ A 201 ( 4.5A)3QZ A 201 (-2.9A)3QZ A 201 (-3.2A)3QZ A 201 (-4.0A) | 0.89A | 4l4eA-5ierA:undetectable | 4l4eA-5ierA:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L4F_A_CAMA503_0 (CAMPHOR5-MONOOXYGENASE) |
5ier | OHP9 (syntheticconstruct) | 4 / 8 | PHE A 59THR A 16THR A 43LEU A 69 | 3QZ A 201 ( 4.5A)3QZ A 201 (-2.9A)3QZ A 201 (-3.2A)3QZ A 201 (-4.0A) | 0.91A | 4l4fA-5ierA:undetectable | 4l4fA-5ierA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M2X_A_TMQA202_2 (DIHYDROFOLATEREDUCTASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 3 / 3 | TRP A 200GLN A 227THR A 199 | 3QZ A 501 (-4.1A)NoneNone | 0.98A | 4m2xA-3qz1A:undetectable | 4m2xA-3qz1A:16.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 11 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206GLY A 301ALA A 302THR A 306VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.28A | 4nkvA-4nkyA:63.7 | 4nkvA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 7 / 12 | LEU A 105ALA A 113PHE A 114ILE A 205ARG A 239ALA A 302VAL A 482 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.4A)3QZ A 601 (-2.9A)3QZ A 601 (-4.1A) | 0.54A | 4nkvA-4nkyA:63.7 | 4nkvA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | LEU A 105ALA A 113PHE A 114ILE A 205GLY A 297 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 ( 3.4A)None | 1.09A | 4nkvA-4nkyA:63.7 | 4nkvA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_A_AERA601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | TYR A 201LEU A 209ASP A 298GLU A 305VAL A 366 | None3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.30A | 4nkvA-4nkyA:63.7 | 4nkvA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_B_AERB601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206LEU A 209GLY A 301ALA A 302THR A 306VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 4.8A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.28A | 4nkvB-4nkyA:63.3 | 4nkvB-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_B_AERB601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | TYR A 201ARG A 239ASP A 298GLU A 305VAL A 366 | None3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.49A | 4nkvB-4nkyA:63.3 | 4nkvB-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_C_AERC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206ARG A 239GLY A 301ALA A 302THR A 306VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 4.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.31A | 4nkvC-4nkyA:60.8 | 4nkvC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_C_AERC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | LEU A 105ALA A 113PHE A 114ILE A 205GLY A 297 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 ( 3.4A)None | 1.11A | 4nkvC-4nkyA:60.8 | 4nkvC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_C_AERC601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 6 | TYR A 201LEU A 209ASP A 298GLU A 305VAL A 366ALA A 367 | None3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A)HEM A 600 ( 3.1A) | 0.28A | 4nkvC-4nkyA:60.8 | 4nkvC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_D_AERD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206ARG A 239GLY A 301ALA A 302THR A 306VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 4.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.32A | 4nkvD-4nkyA:61.4 | 4nkvD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_D_AERD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | LEU A 105ALA A 113PHE A 114ILE A 205GLY A 297 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 ( 3.4A)None | 1.12A | 4nkvD-4nkyA:61.4 | 4nkvD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKV_D_AERD601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | TYR A 201GLY A 297ASP A 298GLU A 305VAL A 366 | NoneNone3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.25A | 4nkvD-4nkyA:61.4 | 4nkvD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_A_STRA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205ILE A 206GLY A 301ALA A 302THR A 306ILE A 371VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 4.6A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 (-3.8A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.21A | 4nkxA-4nkyA:63.6 | 4nkxA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_A_STRA601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 6 | LEU A 209ARG A 239ASP A 298GLU A 305VAL A 366ALA A 367 | 3QZ A 601 ( 4.8A)3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A)HEM A 600 ( 3.1A) | 0.18A | 4nkxA-4nkyA:63.6 | 4nkxA-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_B_STRB601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | ILE A 205LEU A 209ASP A 298GLU A 305VAL A 366 | 3QZ A 601 ( 3.4A)3QZ A 601 ( 4.8A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.22A | 4nkxB-4nkyA:63.5 | 4nkxB-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_C_STRC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | ALA A 113ILE A 206ALA A 302ILE A 371VAL A 366 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.6A)3QZ A 601 (-2.9A)HEM A 600 (-3.8A)HEM A 600 ( 3.4A) | 1.05A | 4nkxC-4nkyA:60.7 | 4nkxC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_C_STRC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205GLY A 301ALA A 302THR A 306ALA A 367ILE A 371VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 ( 3.1A)HEM A 600 (-3.8A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.26A | 4nkxC-4nkyA:60.7 | 4nkxC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_C_STRC601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | ILE A 206ARG A 239ASP A 298GLU A 305VAL A 366 | 3QZ A 601 ( 4.6A)3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.31A | 4nkxC-4nkyA:60.7 | 4nkxC-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_D_STRD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | ALA A 113ILE A 206ALA A 302ILE A 371VAL A 366 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.6A)3QZ A 601 (-2.9A)HEM A 600 (-3.8A)HEM A 600 ( 3.4A) | 1.05A | 4nkxD-4nkyA:60.4 | 4nkxD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_D_STRD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 12 / 12 | LEU A 105ALA A 113PHE A 114ASN A 202ILE A 205GLY A 301ALA A 302THR A 306ALA A 367ILE A 371VAL A 482VAL A 483 | 3QZ A 601 ( 4.2A)HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 ( 3.1A)HEM A 600 (-3.8A)3QZ A 601 (-4.1A)3QZ A 601 (-4.1A) | 0.30A | 4nkxD-4nkyA:60.4 | 4nkxD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKX_D_STRD601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 5 | ILE A 206ARG A 239ASP A 298GLU A 305VAL A 366 | 3QZ A 601 ( 4.6A)3QZ A 601 ( 4.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.4A) | 0.29A | 4nkxD-4nkyA:60.4 | 4nkxD-4nkyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R1Z_A_AERA601_1 (CYP17A1 PROTEIN) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 9 | ALA A 113ASP A 298GLY A 301ALA A 302VAL A 483 | HEM A 600 ( 2.9A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)3QZ A 601 (-4.1A) | 0.96A | 4r1zA-4nkyA:51.1 | 4r1zA-4nkyA:46.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R1Z_A_AERA601_1 (CYP17A1 PROTEIN) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 8 / 9 | ALA A 113TYR A 201ILE A 205ASP A 298GLY A 301ALA A 302THR A 306VAL A 482 | HEM A 600 ( 2.9A)None3QZ A 601 ( 3.4A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A) | 0.68A | 4r1zA-4nkyA:51.1 | 4r1zA-4nkyA:46.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R1Z_B_AERB601_1 (CYP17A1 PROTEIN) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 7 | ALA A 113GLY A 301ALA A 302GLU A 305THR A 306 | HEM A 600 ( 2.9A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)3QZ A 601 ( 4.9A)HEM A 600 ( 3.2A) | 0.64A | 4r1zB-4nkyA:50.5 | 4r1zB-4nkyA:46.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R20_A_AERA602_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 8 | ALA A 113ASN A 202GLY A 301THR A 306VAL A 366 | HEM A 600 ( 2.9A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)HEM A 600 ( 3.2A)HEM A 600 ( 3.4A) | 0.71A | 4r20A-4nkyA:49.9 | 4r20A-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R20_A_AERA602_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 4 / 8 | ASN A 202ILE A 205GLY A 301THR A 306 | 3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)HEM A 600 ( 3.2A) | 0.57A | 4r20A-4nkyA:49.9 | 4r20A-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R20_B_AERB602_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 9 | ALA A 113PHE A 114ASN A 202GLY A 301VAL A 483 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)3QZ A 601 (-4.1A) | 0.94A | 4r20B-4nkyA:49.2 | 4r20B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R20_B_AERB602_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 9 | ALA A 113PHE A 114ASN A 202ILE A 205GLY A 301THR A 306 | HEM A 600 ( 2.9A)3QZ A 601 ( 4.1A)3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)HEM A 600 ( 3.2A) | 0.80A | 4r20B-4nkyA:49.2 | 4r20B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R20_B_AERB602_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 9 | ASN A 202ILE A 205GLY A 301THR A 306VAL A 482 | 3QZ A 601 (-3.5A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A) | 0.81A | 4r20B-4nkyA:49.2 | 4r20B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R21_A_STRA601_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 4 / 6 | ALA A 113ILE A 205GLY A 301ILE A 371 | HEM A 600 ( 2.9A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)HEM A 600 (-3.8A) | 0.78A | 4r21A-4nkyA:49.0 | 4r21A-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R21_B_STRB601_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 9 | ALA A 113GLY A 301ALA A 302ILE A 371VAL A 483 | HEM A 600 ( 2.9A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 (-3.8A)3QZ A 601 (-4.1A) | 0.97A | 4r21B-4nkyA:49.1 | 4r21B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R21_B_STRB601_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 6 / 9 | ALA A 113ILE A 205GLY A 301ALA A 302THR A 306ILE A 371 | HEM A 600 ( 2.9A)3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)HEM A 600 (-3.8A) | 0.89A | 4r21B-4nkyA:49.1 | 4r21B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R21_B_STRB601_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 9 | ILE A 205GLY A 301ALA A 302THR A 306VAL A 482 | 3QZ A 601 ( 3.4A)3QZ A 601 ( 3.0A)3QZ A 601 (-2.9A)HEM A 600 ( 3.2A)3QZ A 601 (-4.1A) | 0.86A | 4r21B-4nkyA:49.1 | 4r21B-4nkyA:44.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_A_STRA604_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 6 / 12 | VAL A 101ASP A 107SER A 109ARG A 232VAL A 358LEU A 362 | NoneNone3QZ A 501 (-3.8A)3QZ A 501 (-3.8A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.98A | 4y8wA-3qz1A:52.3 | 4y8wA-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_A_STRA604_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 7 / 12 | VAL A 101SER A 109TRP A 200ARG A 232ASP A 286VAL A 358LEU A 362 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.1A)3QZ A 501 (-3.8A)3QZ A 501 ( 4.7A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.78A | 4y8wA-3qz1A:52.3 | 4y8wA-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_A_STRA604_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 5 / 12 | VAL A 101SER A 109TRP A 200ASP A 286GLY A 290 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.1A)3QZ A 501 ( 4.7A)3QZ A 501 (-3.9A) | 1.06A | 4y8wA-3qz1A:52.3 | 4y8wA-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_A_STRA604_1 (CYTOCHROME P45021-HYDROXYLASE) |
5vbu | CYTOCHROME P45021-HYDROXYLASE (Homosapiens) | 12 / 12 | VAL A 101ASP A 107SER A 109VAL A 198LEU A 199TRP A 202ARG A 234ASP A 288ILE A 291GLY A 292VAL A 360LEU A 364 | 3QZ A 502 (-4.5A)3QZ A 502 ( 3.8A)3QZ A 502 ( 3.5A)3QZ A 502 (-4.6A)3QZ A 502 ( 4.7A)3QZ A 502 ( 3.9A)3QZ A 502 (-3.8A)3QZ A 502 (-4.0A)3QZ A 502 (-4.3A)3QZ A 502 ( 3.2A)HEM A 501 ( 4.3A)3QZ A 502 (-4.1A) | 0.31A | 4y8wA-5vbuA:63.3 | 4y8wA-5vbuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 6 / 12 | VAL A 101ASP A 107SER A 109ARG A 232VAL A 358LEU A 362 | NoneNone3QZ A 501 (-3.8A)3QZ A 501 (-3.8A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.97A | 4y8wB-3qz1A:52.1 | 4y8wB-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 5 / 12 | VAL A 101SER A 109ASP A 286GLY A 290VAL A 469 | None3QZ A 501 (-3.8A)3QZ A 501 ( 4.7A)3QZ A 501 (-3.9A)None | 1.11A | 4y8wB-3qz1A:52.1 | 4y8wB-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 7 / 12 | VAL A 101SER A 109TRP A 200ARG A 232ASP A 286VAL A 358LEU A 362 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.1A)3QZ A 501 (-3.8A)3QZ A 501 ( 4.7A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.72A | 4y8wB-3qz1A:52.1 | 4y8wB-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 5 / 12 | VAL A 101SER A 109TRP A 200ASP A 286GLY A 290 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.1A)3QZ A 501 ( 4.7A)3QZ A 501 (-3.9A) | 1.03A | 4y8wB-3qz1A:52.1 | 4y8wB-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
5vbu | CYTOCHROME P45021-HYDROXYLASE (Homosapiens) | 12 / 12 | VAL A 101ASP A 107SER A 109VAL A 198LEU A 199TRP A 202ARG A 234ASP A 288ILE A 291GLY A 292VAL A 360LEU A 364 | 3QZ A 502 (-4.5A)3QZ A 502 ( 3.8A)3QZ A 502 ( 3.5A)3QZ A 502 (-4.6A)3QZ A 502 ( 4.7A)3QZ A 502 ( 3.9A)3QZ A 502 (-3.8A)3QZ A 502 (-4.0A)3QZ A 502 (-4.3A)3QZ A 502 ( 3.2A)HEM A 501 ( 4.3A)3QZ A 502 (-4.1A) | 0.32A | 4y8wB-5vbuA:63.5 | 4y8wB-5vbuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_C_STRC603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 6 / 12 | VAL A 101ASP A 107SER A 109ARG A 232VAL A 358LEU A 362 | NoneNone3QZ A 501 (-3.8A)3QZ A 501 (-3.8A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.95A | 4y8wC-3qz1A:52.0 | 4y8wC-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_C_STRC603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 5 / 12 | VAL A 101SER A 109LEU A 110GLY A 290VAL A 469 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.3A)3QZ A 501 (-3.9A)None | 1.03A | 4y8wC-3qz1A:52.0 | 4y8wC-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_C_STRC603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 8 / 12 | VAL A 101SER A 109LEU A 110TRP A 200ILE A 229ARG A 232VAL A 358LEU A 362 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.3A)3QZ A 501 (-4.1A)None3QZ A 501 (-3.8A)HEM A 500 (-4.3A)HEM A 500 (-4.7A) | 0.91A | 4y8wC-3qz1A:52.0 | 4y8wC-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_C_STRC603_1 (CYTOCHROME P45021-HYDROXYLASE) |
3qz1 | STEROID21-HYDROXYLASE (Bostaurus) | 6 / 12 | VAL A 101SER A 109LEU A 110TRP A 200ILE A 229GLY A 290 | None3QZ A 501 (-3.8A)3QZ A 501 (-4.3A)3QZ A 501 (-4.1A)None3QZ A 501 (-3.9A) | 1.18A | 4y8wC-3qz1A:52.0 | 4y8wC-3qz1A:75.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Y8W_C_STRC603_1 (CYTOCHROME P45021-HYDROXYLASE) |
5vbu | CYTOCHROME P45021-HYDROXYLASE (Homosapiens) | 12 / 12 | VAL A 101ASP A 107SER A 109LEU A 110VAL A 198TRP A 202ILE A 231ARG A 234ILE A 291GLY A 292VAL A 360LEU A 364 | 3QZ A 502 (-4.5A)3QZ A 502 ( 3.8A)3QZ A 502 ( 3.5A)3QZ A 502 ( 4.8A)3QZ A 502 (-4.6A)3QZ A 502 ( 3.9A)3QZ A 502 (-4.8A)3QZ A 502 (-3.8A)3QZ A 502 (-4.3A)3QZ A 502 ( 3.2A)HEM A 501 ( 4.3A)3QZ A 502 (-4.1A) | 0.20A | 4y8wC-5vbuA:64.5 | 4y8wC-5vbuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5X24_A_LSNA502_1 (CYTOCHROME P450 2C9) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | PHE A 114VAL A 236ASP A 298GLY A 301THR A 306 | 3QZ A 601 ( 4.1A)None3QZ A 601 (-3.5A)3QZ A 601 ( 3.0A)HEM A 600 ( 3.2A) | 1.20A | 5x24A-4nkyA:42.6 | 5x24A-4nkyA:32.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CHG_C_SAMC1101_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-4 SPECIFIC) |
4nky | STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE (Homosapiens) | 5 / 12 | ILE A 205ASN A 200SER A 168ASN A 202LEU A 485 | 3QZ A 601 ( 3.4A)NoneNone3QZ A 601 (-3.5A)None | 1.34A | 6chgC-4nkyA:undetectable | 6chgC-4nkyA:15.48 |